NCT02558595View on ClinicalTrials.gov

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 22, 2015

Primary Completion Date

December 18, 2017

Study Completion Date

December 18, 2017

Conditions
Polycystic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Niacinamide

OTHER

Placebo

Placebo pill that matches niacinamide pill is size, shape and color

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Kansas Medical Center

OTHER

NCT02558595 - Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) | Biotech Hunter | Biotech Hunter